Stockreport

Trevi Therapeutics to Participate in Upcoming March Conferences

Trevi Therapeutics, Inc.  (TRVI) 
PDF NEW HAVEN, Conn., March 02, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational [Read more]